SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Oncology Pharmacy Practice
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lau, K. K
Right arrow Articles by Jones, D. P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lau, K. K
Right arrow Articles by Jones, D. P
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Polyuria associated with high-dose methotrexate in two patients with acute lymphoblastic leukaemia

Keith K Lau, MD

Department of Pediatrics, University of Tennessee Health Sciences Center, Memphis, TN, USA, Le Bonheur Children’s Medical Center, Memphis, TN, USA

Aaron R Weiss, DO

St Jude Children’s Research Hospital, Memphis, TN, USA

Deborah P Jones, MD

Department of Pediatrics, University of Tennessee Health Sciences Center, Memphis, TN, USA, Le Bonheur Children’s Medical Center, Memphis, TN, USA

Although methotrexate has an established safety profile in clinical practice, severe morbidity can still occur on rare occassions. We report two patients with leukemia treated with high dose methotrexate. Both patients developed profound polyuria that required aggressive fluid resuscitations during the treatments. Renal toxicity is a known complication of methotrexate, but polyuria associated with its use has not been reported before. Polyuria started shortly after the initiation of the medicine in both patients. The polyuria resolved as the drug level in blood became undetectable. The episodes of polyuria were transient and recurred every time when the patients received methotrexate. The clinical pictures were not compatible with classical drug induced nephrogenic diabetes insipidus. It is possible that the drug interferes with adenosine metabolism, which in turn alters the tubular ability of solute and fluid reabsorption.

Key Words: adenosine • methotrexate • nephrogenic diabetes insipidus • polyuria

Journal of Oncology Pharmacy Practice, Vol. 11, No. 1, 31-33 (2005)
DOI: 10.1191/1078155205jp148oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement